Your Results Matter Every Day

Sensitive, Versatile Agilent SARS-CoV-2 qRT-PCR Dx Test

Get The Datasheet

For more information on the Agilent SARS-CoV-2 qRT-PCR Dx kit, product performance and assay specifications, please download the data sheet.

Download now

Sensitive. Efficient. Reliable.

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. Clinical laboratories can easily generate diagnostic results from this single-tube assay. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens¹ obtained from individuals suspected of having COVID-19 by their healthcare provider.

The SARS-CoV-2 qRT-PCR Dx kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments.

The Agilent SARS-CoV-2 qRT-PCR Dx kit has been designed for flexibility across the entire workflow. The open system has been validated with two commercially available RNA extraction products and three real-time PCR systems, including the AriaDx Real-Time PCR System*.

Key Benefits

Efficient, single-tube assay

Single-tube qRT-PCR assay includes three targets: N1 and N2 viral targets and human RNase P
Minimizes use of consumables and maximizes sample throughput per instrument run
Available as an optional stand-alone positive control

Sensitive, reliable assay

Developed using primer and probe sequences published by the U.S. Centers for Disease Control (CDC)¹
Clinically validated and demonstrated with a limit of detection as low as 1.0 copy per µL

Validated, flexible workflow

Choose from automated RNA extraction platforms
Protocols for established 96-well real-time PCR systems, including the Agilent AriaDx Real-Time PCR System*
Enables easy assay adoption on existing instruments

Experience a qPCR workflow that fits your laboratory.

For the Agilent SARS-CoV-2 qRT-PCR Dx kit protocol, see the product page or download the Instructions for Use (IFU).

¹ Centers for Disease Control and Prevention, Division of Viral Diseases. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. CDC/DDID/NCIRD/ Division of Viral (2020), DiseasesCDC-006-00019, Revision: 06. https://www.fda.gov/media/134922/download

For In Vitro Diagnostic Use.

The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC.

*The SARS-CoV-2 qRT-PCR Dx kit can be used with the AriaDx or AriaMx Real-Time PCR System. For countries requiring the use of In Vitro Diagnostic instruments, the AriaDx System must be used.

Not for sale in the US.

Looking for additional information on the new Agilent SARS-CoV-2 qPCR Dx test?

Please fill out your contact information below and an Agilent representative will be in touch with you shortly.